Glycine for Sleep: The Amino Acid That Lowers Your Core Body Temperature
Most sleep supplements work on one of two mechanisms: they raise melatonin or they potentiate GABA. Glycine does neither. It improves sleep onset and quality by lowering core body temperature — a process that is, physiologically speaking, the body's primary signal that it is time to sleep. That distinction matters, because targeting a different mechanism means glycine can stack with other sleep aids without redundancy, and its tolerability profile is exceptionally clean.
What Glycine Actually Is
Glycine is the smallest amino acid and the only one that is not chiral — it has no L or D form. The body synthesizes it from serine and threonine, so it is technically non-essential, but dietary intake and endogenous synthesis may not be sufficient under conditions of high demand. It is present in collagen (roughly 35 percent of collagen by weight is glycine), which means bone broth and collagen-containing foods are meaningful dietary sources. Average dietary intake is estimated at 1.5–3 grams per day, but therapeutic sleep doses are typically 3 grams taken immediately before bed.
The Core Temperature Mechanism
Core body temperature must drop by approximately 1–2°C to initiate sleep. This happens through vasodilation in the extremities — heat is redirected from the body core to the skin surface and dissipated. People who struggle with sleep onset often have impaired thermoregulatory responses or sleep in environments that are too warm to allow this transition.
Research published in Sleep and Biological Rhythms (2006) and subsequently confirmed in a 2012 study in Neuropsychopharmacology found that oral glycine administration significantly lowered core body temperature in rats and humans, facilitated by peripheral vasodilation. In the 2012 human trial led by Bannai et al., participants who took 3 grams of glycine before bed reported significantly reduced fatigue the next morning and demonstrated improvements on psychomotor vigilance tasks — a validated measure of sleep quality. Crucially, they reached slow-wave sleep faster.
Effects on Sleep Architecture
Where many sleep supplements produce sedation that flattens sleep architecture — reducing REM and slow-wave sleep in the process — glycine appears to preserve or enhance the quality of each stage. The Bannai 2012 trial specifically noted increases in slow-wave sleep without corresponding reductions in REM. A later study in Frontiers in Neurology (2017) supported this, finding that glycine-treated participants showed improved subjective sleep quality on the Pittsburgh Sleep Quality Index without morning sedation or dependency.
This is mechanistically coherent: glycine acts as an inhibitory neurotransmitter in the spinal cord and brainstem (via glycine receptors, distinct from GABA receptors), suppressing motor activity during sleep and reducing the likelihood of microarousals. It also modulates NMDA receptors in the suprachiasmatic nucleus — the brain's circadian clock — which may contribute to the next-day alertness users consistently report.
Glycine vs. Other Sleep Amino Acids
Tryptophan converts to serotonin and then melatonin, making it an indirect melatonin precursor. L-theanine increases alpha wave activity and reduces anxiety, improving sleep onset in people whose insomnia is anxiety-driven. Glycine works downstream of both: it targets the thermoregulatory and arousal systems directly, without the dependency risk or receptor desensitization that can develop with synthetic GABA modulators. For people whose sleep problem is getting into deep sleep rather than falling asleep, glycine is often the more relevant intervention.
Glycine also combines well with magnesium glycinate — both share the glycine moiety and act via complementary mechanisms, with magnesium addressing GABA pathway support and glycine handling thermoregulation and brainstem inhibition.
Dosing and Timing
The dose used in the highest-quality human trials is 3 grams, taken 30–60 minutes before sleep. Glycine has a relatively flat dose-response curve for sleep — there is no established benefit to exceeding 3–5 grams, and the compound is well-tolerated at these amounts. It has a slightly sweet taste, which makes powder form easy to dissolve in water. Capsule forms are available for those who prefer exact dosing without measuring.
Safety data from the broader amino acid literature places no cause for concern at these doses. Glycine is not classified as a drug, causes no known drug interactions at therapeutic doses, and does not appear to suppress endogenous synthesis in supplementation trials. It is worth noting that glycine is also studied for its role in joint and connective tissue health — the same dose that supports sleep also contributes to collagen synthesis, which may be a useful secondary effect for athletes.
What the Research Does Not Show
Most glycine sleep trials are small (20–30 participants), short-term (two to four weeks), and conducted in populations with self-reported poor sleep. Long-term data on glycine supplementation specifically for sleep is limited. The core temperature mechanism is well-supported, but the degree of effect varies between individuals — those with good thermoregulatory function may notice less benefit than those whose sleep quality is partly temperature-mediated. Glycine is not a pharmaceutical-grade intervention and should not be positioned as a primary treatment for sleep disorders with clinical severity.